On November 23, 2016, EFSA will present its draft guidance document on allergenicity of genetically modified ("GM") plants at a meeting in Parma, Italy. EFSA invites representatives of Member States, scientific experts, NGOs, industry, and international partners to participate. The assessment of potential allergenicity is an integral part of the overall risk assessment of GM plants before being commercialized in the EU.
The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.
